ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 187 filers reported holding ACORDA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $223,000 | -93.8% | 11,345 | -94.6% | 0.00% | -100.0% |
Q2 2018 | $3,609,000 | +17.2% | 208,410 | -3.8% | 0.01% | +20.0% |
Q1 2018 | $3,080,000 | +18.3% | 216,539 | -1.9% | 0.01% | 0.0% |
Q4 2017 | $2,604,000 | -19.9% | 220,645 | +60.5% | 0.01% | -28.6% |
Q3 2017 | $3,252,000 | +175.4% | 137,511 | +129.4% | 0.01% | +133.3% |
Q2 2017 | $1,181,000 | +524.9% | 59,943 | +494.8% | 0.00% | – |
Q4 2016 | $189,000 | -42.2% | 10,077 | -35.7% | 0.00% | -100.0% |
Q3 2016 | $327,000 | -28.0% | 15,670 | -11.9% | 0.00% | 0.0% |
Q2 2016 | $454,000 | +27.9% | 17,782 | +32.6% | 0.00% | 0.0% |
Q1 2016 | $355,000 | -42.2% | 13,408 | -6.6% | 0.00% | -50.0% |
Q4 2015 | $614,000 | +82.2% | 14,356 | +13.0% | 0.00% | +100.0% |
Q3 2015 | $337,000 | -13.1% | 12,709 | +9.0% | 0.00% | 0.0% |
Q2 2015 | $388,000 | -0.5% | 11,655 | -0.6% | 0.00% | -50.0% |
Q1 2015 | $390,000 | -24.4% | 11,729 | -7.1% | 0.00% | -33.3% |
Q4 2014 | $516,000 | – | 12,628 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 325,000 | $8,289,000 | 2.39% |
ARMISTICE CAPITAL, LLC | 232,000 | $5,917,000 | 2.25% |
SENZAR ASSET MANAGEMENT, LLC | 358,191 | $9,135,662,000 | 1.99% |
SCOPIA CAPITAL MANAGEMENT LP | 3,171,229 | $80,882,000 | 1.67% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,029,410 | $26,255,000 | 1.03% |
Baker Brothers Advisors | 3,661,082 | $93,376,000 | 0.98% |
ARBOR CAPITAL MANAGEMENT LLC | 58,783 | $1,499,000 | 0.79% |
Spark Investment Management LLC | 292,400 | $7,457,000 | 0.70% |
SPHERA FUNDS MANAGEMENT LTD. | 98,000 | $2,499,000 | 0.65% |
Virtus ETF Advisers LLC | 21,130 | $539,000 | 0.40% |